Effectiveness of an association of a cranberry dry extract, D-mannose, and the two microorganisms Lactobacillus plantarum LP01 and Lactobacillus paracasei LPC09 in women affected by cystitis: A pilot study

Journal of Clinical Gastroenterology

Volumn 48, Issue , 2014, Pages S96-S101

  Vicariotto, Franco ^a  

^a Gynaecology Unit San Pio X Nursing Home   (Italy)

Author keywords

Acute cystitis; Barrier effect; Cranberry extract; Gelling complex; Lactobacilli

Indexed keywords

CRANBERRY EXTRACT; ESTERASE; MANNOSE; NITRITE; BACTERIAL POLYSACCHARIDE; BIOLOGICAL MARKER; CARBOXYLESTERASE; EXOPOLYSACCHARIDE, STREPTOCOCCUS; GEL; LEUKOCYTE ESTERASE; PLANT EXTRACT; PLANT GUM; PROBIOTIC AGENT; TARA GUM; URINARY TRACT AGENT;

ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; CYSTITIS; DRUG EFFICACY; DYSURIA; FEMALE; FOLLOW UP; HEMATURIA; HUMAN; LACTOBACILLUS PARACASEI; LACTOBACILLUS PLANTARUM; LEUKOCYTE; MICTURITION DISORDER; PILOT STUDY; PREMENOPAUSE; PROSPECTIVE STUDY; TREATMENT OUTCOME; URINALYSIS; URINARY URGENCY; ACUTE DISEASE; CHEMISTRY; CLINICAL TRIAL; CRANBERRY; FRUIT; GEL; GROWTH, DEVELOPMENT AND AGING; MEDICINAL PLANT; METABOLISM; MICROBIOLOGY; MULTIMODALITY CANCER THERAPY; PHYTOTHERAPY; TIME; URINE;

ACUTE DISEASE; BIOLOGICAL MARKERS; CARBOXYLIC ESTER HYDROLASES; COMBINED MODALITY THERAPY; CYSTITIS; FEMALE; FRUIT; GELS; HUMANS; LACTOBACILLUS PLANTARUM; MANNOSE; NITRITES; PHYTOTHERAPY; PILOT PROJECTS; PLANT EXTRACTS; PLANT GUMS; PLANTS, MEDICINAL; POLYSACCHARIDES, BACTERIAL; PROBIOTICS; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; UROLOGICAL AGENTS; VACCINIUM MACROCARPON;

EID: 84916604379     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0000000000000224     Document Type: Conference Paper

References (39)

1. Nicolle LE. Urinary tract infection. Crit Care Clin. 2013; 29:699-715.
2. Ejrnæs K. Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli. Dan Med Bull. 2011;58:B4187.
3. Colgan R, Williams M. Diagnosis and treatment of acute uncomplicated cystitis. Am Fam Physician. 2011;84:771-776.
4. Gupta K, Scholes D, Stamm WE. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA. 1999;281:736-738.
5. Ulett GC, Totsika M, Schaale K, et al. Uropathogenic Escherichia coli virulence and innate immune responses during urinary tract infection. Curr Opin Microbiol. 2013;16:100-107.
6. Little P, Turner S, Rumsby K, et al. Developing clinical rules to predict urinary tract infection in primary care settings: sensitivity and specificity of near patient tests (dipsticks) and clinical scores. Br J Gen Pract. 2006;56:606-612.
7. McIsaac WJ, Low DE, Biringer A, et al. The impact of empirical management of acute cystitis on unnecessary antibiotic use. Arch Intern Med. 2002;162:600-605.
8. Giesen LG, Cousins G, Dimitrov BD, et al. Predicting acute uncomplicated urinary tract infection in women: a systematic review of the diagnostic accuracy of symptoms and signs. BMC Fam Pract. 2010;11:78.
9. Nicolle LE. Asymptomatic bacteriuria: when to screen and when to treat. Infect Dis Clin North Am. 2003;17:367-394.
10. Bent S, Nallamothu BK, Simel DL, et al. Does this woman have an acute uncomplicated urinary tract infection? JAMA. 2002;287:2701-2710.
11. Brumfitt W, Gargan RA, Hamilton-Miller JM. Periurethral enterobacterial carriage preceding urinary infection. Lancet. 1987;1:824-826.
12. Stamey TA, Sexton CC. The role of vaginal colonization with enterobacteriaceae in recurrent urinary infections. J Urol. 1975;113:214-217.
13. Hooton TM, Scholes D, Stapleton AE, et al. A prospective study of asymptomatic bacteriuria in sexually active young women. N Engl J Med. 2000;343:992-997.
14. Ferry S, Burman LG, Mattsson B. Urinary tract infection in primary health care in northern Sweden. I. Epidemiology. Scand J Prim Health Care. 1987;5:123-128.
15. Foxman B. Recurring urinary tract infection: incidence and risk factors. Am J Public Health. 1990;80:331-333.
16. Kärkkäinen UM, Ikäheimo R, Katila ML, et al. Recurrence of urinary tract infections in adult patients with communityacquired pyelonephritis caused by E. Coli: a 1-year follow-up. Scand J Infect Dis. 2000;32:495-499.
17. Gupta K. Emerging antibiotic resistance in urinary tract pathogens. Infect Dis Clin North Am. 2003;17:243-259.
18. Anderson GG, Palermo JJ, Schilling JD, et al. Intracellular bacterial biofilm-like pods in urinary tract infections. Science. 2003;301:105-107.
19. Mabbett AN, Ulett GC, Watts RE, et al. Virulence properties of asymptomatic bacteriuria Escherichia coli. Int J Med Microbiol. 2009;299:53-63.
20. Beloin C, Roux A, Ghigo JM. Escherichia coli biofilms. Curr Top Microbiol Immunol. 2008;322:249-289.
21. Danese PN, Pratt LA, Dove SL, et al. The outer membrane protein, antigen 43, mediates cell-to-cell interactions within Escherichia coli biofilms. Mol Microbiol. 2000;37:424-432.
22. Schembri MA, Kjaergaard K, Klemm P. Global gene expression in Escherichia coli biofilms. Mol Microbiol. 2003; 48:253-267.
23. Yang SP, Chen YY, Hsu HS, et al. A risk factor analysis of healthcare-associated fungal infections in an intensive care unit: a retrospective cohort study. BMC Infect Dis. 2013;13:10.
24. Sánchez Ballester F, Ruiz Vidal V, López Alcina E, et al. M. Cysticleans a highly pac standardized content in the prevention of recurrent urinary tract infections: an observational, prospective cohort study. BMC Urol. 2013;13:28.
25. Gupta K, Chou MY, Howell A, et al. Cranberry products inhibit adherence of p-fimbriated Escherichia coli to primary cultured bladder and vaginal epithelial cells. J Urol. 2007;177:2357-2360.
26. Blumberg JB, Camesano TA, Cassidy A, et al. Cranberries and their bioactive constituents in human health. Adv Nutr. 2013;4:618-632.
27. Kranjčec B, Papeš D, Altarac S. D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World J Urol. 2014;32:79-84.
28. Ofek I, Beachey EH. Mannose binding and epithelial cell adherence of Escherichia coli. Infect Immun. 1978;22:247-254.
29. Hung CS, Bouckaert J, Hung D, et al. Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection. Mol Microbiol. 2002;44:903-915.
30. Firon N, Ashkenazi S, Mirelman D, et al. Aromatic alphaglycosides of mannose are powerful inhibitors of the adherence of type 1 fimbriated Escherichia coli to yeast and intestinal epithelial cells. Infect Immun. 1987;55:472-476.
31. Mogna L, Del Piano M, Deidda F, et al. Assessment of the in vitro inhibitory activity of specific probiotic bacteria against different Escherichia coli strains. J Clin Gastroenterol. 2012; 46(suppl):S29-S32.
32. Clayson D, Wild D, Doll H, et al. Validation of a patientadministered questionnaire to measure the severity and bothersomeness of lower urinary tract symptoms in uncomplicated urinary tract infection (UTI): the UTI Symptom Assessment questionnaire. BJU Int. 2005;96:350-359.
33. Trivedi D, Jena PK, Seshadri S. Colicin E2 Expression in Lactobacillus brevis DT24, a vaginal probiotic isolate, against uropathogenic Escherichia coli. ISRN Urol. 2014;2014:869610.
34. Reid G, Bruce AW, Fraser N, et al. Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbiol. 2001;30:49-52.
35. Dani C, Biadaioli R, Bertini G, et al. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate. 2002;82:103-108.
36. Grin PM, Kowalewska PM, Alhazzan W, et al. Lactobacillus for preventing recurrent urinary tract infections in women: meta-analysis. Can J Urol. 2013;20:6607-6614.
37. Dugoua JJ, Seely D, Perri D, et al. Safety and efficacy of cranberry (Vaccinium macrocarpon) during pregnancy and lactation. Can J Clin Pharmacol. 2008;15:e80-e86.
38. Colgan R, Hyner S, Chu S. Uncomplicated urinary tract infections in adults. In: GrabeM, Bishop MC, Bjerklund-Johansen TE, et al, eds. Guidelines on Urological Infections. Arnhem, The Netherlands: European Association of Urology; 2009:11-38.
39. Whiting P, Westwood M, Bojke L, et al. Clinical effectiveness and cost-effectiveness of tests for the diagnosis and investigation of urinary tract infection in children: a systematic review and economic model. Health Technol Assess. 2006; 10:iii-i, xi-xiii, 1-154.